1. Home
  2. TNL vs TVTX Comparison

TNL vs TVTX Comparison

Compare TNL & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travel   Leisure Co.

TNL

Travel Leisure Co.

HOLD

Current Price

$79.28

Market Cap

4.7B

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$65.94

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNL
TVTX
Founded
1990
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.3B
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
TNL
TVTX
Price
$79.28
$65.94
Analyst Decision
Buy
Strong Buy
Analyst Count
7
13
Target Price
$84.00
$40.62
AVG Volume (30 Days)
833.7K
1.3M
Earning Date
04-22-2026
05-04-2026
Dividend Yield
3.80%
N/A
EPS Growth
N/A
92.89
EPS
2.94
N/A
Revenue
$4,021,000,000.00
N/A
Revenue This Year
$3.56
$44.76
Revenue Next Year
$3.55
$35.51
P/E Ratio
$26.55
N/A
Revenue Growth
4.06
N/A
52 Week Low
$57.79
$15.60
52 Week High
$81.00
$60.10

Technical Indicators

Market Signals
Indicator
TNL
TVTX
Relative Strength Index (RSI) 61.29 N/A
Support Level $71.58 N/A
Resistance Level $81.00 N/A
Average True Range (ATR) 2.22 0.00
MACD 0.31 0.00
Stochastic Oscillator 99.71 0.00

Price Performance

Historical Comparison
TNL
TVTX

About TNL Travel Leisure Co.

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: